New Drugs

The following items were added to the drug file for September 2009.

Drug Name Form Strength Qty
APO-Clotrimazole 6 Day Vag-Crm 1%, 35g 1
APO-Clotrimazole 3 Day Vag-Crm 2%, 20g 1
APO-Fluconazole One Cap 150mg 1
APO-Gliclazide MR Tab-SR 30mg 100
APO-Glimepiride Tab 1mg 30
APO-Glimepiride Tab 2mg 30
APO-Glimepiride Tab 3mg 30
APO-Glimepiride Tab 4mg 30
APO-Paracetamol # Tab 500mg (bottle) 100
APO-Paracetamol # Tab 500mg (bottle) 300
APO-Pravastatin # Tab 10mg 30
Cephalexin generichealth # Cap 500mg 20
Clonea ^ Crm 1%, 20g 2
CM Gliclazide MR Tab-SR 30mg 100
Diaformin XR Tab-SR 500mg, 120 1
Flamazine Crm 1%, 50g 1
Flamazine Crm 1%, 500g 1
Fludarabine Actavis Inj 50mg 5
Glucose (PK) # Vl 5%,iv infn,1L 5
Lodam # Cap 50mg 20
Lodam SR # Tab-SR 100mg 20
Lodam SR # Tab-SR 150mg 20
Lodam SR # Tab-SR 200mg 20
LoxaLate Tab 10mg 28
LoxaLate Tab 20mg 28
Metex XR Tab-SR 500mg, 120 1
Roxithromycin-GA Tab 150mg 10
Roxithromycin-GA Tab 300mg 5
Sculptra # Inj 150mg 2
Sodibic ^ Cap 840mg 100
Sodium Chloride (PK) # Vl 0.9%,iv infn,1L 5
Sodium Lactate Co Inf-IV 1L 5
Tamiflu Cap 30mg 10
Tamiflu Cap 45mg 10
TW Gliclazide MR Tab-SR 30mg 100
Zoton FasTabs # Tab 30mg 28

# Item has more than one listing in the PBS book
^ Additional PBS listing(s) for an existing drug

Reciprocal Health Care Agreements

An alteration has been made to the explanatory notes in the September 2009 PBS Schedule, adding Belgium to the list of countries which have Reciprocal Health Care Agreements with Australia. PBS subsidies are now available to foreign visitors from Belgium, in addition to those from the United Kingdom, Ireland, New Zealand, Malta, Italy, Sweden, the Netherlands, Finland and Norway.

New and Revised CMIs

The following CMIs are new or revised for September 2009.

CMI Name Status
Actilyse New
Afinitor New
Apidra Revised
Apo-Gliclazide MR New
Apo-Glimepiride New
Apo-Lisinopril Revised
Aptivus New
Atrovent Aerosol CFC Free New
Atrovent Inhalation Solution New
Buscopan Ampoules New
Buscopan Tablets New
Chemmart Amoxycillin and Clavulanic Acid 875mg/125mg Revised
Chemmart Gliclazide Revised
Chemmart Gliclazide MR New
Chemmart Lisinopril Revised
Concerta Revised
Cymbalta Revised
Diaformin XR Revised
Dizole One Revised
Dostinex Revised
Effient New
Enlafax XR New
Eraxis New
Eskazole Revised
Famvir for cold sores Revised
Famvir for genital herpes Revised
Famvir for shingles Revised
Finacea New
GenRx Amoxycillin and Clavulanic Acid 875mg/125mg Revised
GenRx Gliclazide Revised
Haldol Revised
Humira Revised
Imukin New
Infanrix Hexa (thiomersal free) New
Konakion MM Injection Revised
MabtheraNHL/Mabthera RA Revised
Meningitec Revised
Metalyse New
Metomax Revised
Nurofen Plus Revised
Omeprazole Winthrop Revised
Paxtine Revised
Perivasc Revised
Premarin Revised
Premia Continuous Revised
Prevenar Revised
Rapamune Oral Solution Revised
Rapamune Tablets Revised
RotaTeq Revised
Singulair Revised
Tazocin EF Revised
Terry White Chemists Amoxycillin and Clavulanic Acid 875mg/125mg Revised
Terry White Chemists Gliclazide Revised
Terry White Chemists Gliclazide MR New
Terry White Chemists Lisinopril Revised
Timoptol-XE Revised
Viramune Revised
Xeloda Revised
Zometa Revised
Zoton FasTabs New

Withdrawn CMIs

The following CMIs are withdrawn as of September 2009.

CMI Name Status
Chemmart Diltiazem CD Withdrawn
Ciprofloxacin Withdrawn
Colazide Withdrawn
Floxapen Syrup Withdrawn
Metformin HCl Withdrawn
Terry White Chemists Captopril Withdrawn
Terry White Chemists Diltiazem CD Capsules Withdrawn